BofA Securities Downgrades Bausch Health Companies (BHC) to Underperform
Tweet
Share
E-mailGet Alerts BHC Hot Sheet
Price: $7.67 --0%
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 7 | New: 20
Rating Summary:
15 Buy, 11 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 7 | New: 20
Join SI Premium – FREE
BofA Securities downgraded Bausch Health Companies (NYSE: BHC) from Neutral to Underperform with a price target of $27.00.
For an analyst ratings summary and ratings history on Bausch Health Companies click here. For more ratings news on Bausch Health Companies click here.
Shares of Bausch Health Companies closed at $31.66 yesterday.
You May Also Be Interested In
- Morgan Stanley Downgrades Southern Copper (SCCO) to Equalweight
- Exane BNP Paribas Downgrades Koninklijke KPN NV (KPN:NA) (KKPNY) to Neutral
- Wells Fargo Downgrades Xenia Hotels & Resorts (XHR) to Equal Weight
Create E-mail Alert Related Categories
DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
